Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the australian imaging biomarker lifestyle study

Journal of Alzheimer's Disease

Volumn 27, Issue 4, 2011, Pages 909-922

  Faux, Noel G ^a   Ellis, Kathryn A ^a   Porter, Lorine ^b   Fowler, Chris J ^a   Laws, Simon M ^c,d   Martins, Ralph N ^c,d   Pertile, Kelly K ^a   Rembach, Alan ^a   Rowe, Chris C ^a   Rumble, Rebecca L ^a   Szoeke, Cassandra ^e   Taddei, Kevin ^a,c   Taddei, Tania ^c,d   Trounson, Brett O ^a   Villemagne, Victor L ^a   Ward, Vanessa ^a,c   Ames, David ^a,f   Masters, Colin L ^a   Bush, Ashley I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Southern Health   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

^d HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^e CSIRO   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Alzheimer's disease; biomarker; folate; homocysteine; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID BLOOD LEVEL; ARTICLE; AUSTRALIA; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EPISODIC MEMORY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 84455193374     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110752     Document Type: Article

References (78)

1. Alzheimers Disease International (2009) World Alzheimer Report 2009, http://www.alz.co.uk/research/files/WorldAlzheimerReport. pdf
2. Masters CL, Cappai R, Barnham KJ, Villemagne VL (2006) Molecular mechanisms for alzheimers disease: implications for neuroimaging and therapeutics. J Neurochem 97, 1700-1725 (Pubitemid 43873662)
3. Riggs KM, Spiro A, Tucker K, Rush D (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63, 306-314 (Pubitemid 26074688)
4. Lepara O, Alajbegovic A, Zaciragic A, Nakas-Icindic E, Valjevac A, Lepara D, Hadzovic-Dzuvo A, Fajkic A, Kulo A, Sofic E (2009) Elevated serum homocysteine level is not associated with serum C-reactive protein in patients with probable Alzheimers disease. J Neural Transm 116, 1651-1656
5. Morris MS, Jacques PF, Rosenberg IH, Selhub J, Survey NHaNE (2001) Hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 73, 927-933 (Pubitemid 32405990)
6. Bell IR, Edman JS, Selhub J, Morrow FD, Marby DW, Kayne HL, Cole JO (1992) Plasma homocysteine in vascular disease and in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 86, 386-390
7. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C (2001) Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 12, 309-313 (Pubitemid 32656662)
8. Oulhaj A, Refsum H, Beaumont H,Williams J, King E, Jacoby R, Smith AD (2010) Homocysteine as a predictor of cognitive decline in Alzheimers disease. Int J Geriatr Psychiatry 25, 82-90
9. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol 150, 283-289 (Pubitemid 29344955)
10. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM(1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55, 1449-1455 (Pubitemid 28525506)
11. Mizrahi EH, Bowirrat A, Jacobsen DW, Korczyn AD, Traore F, Petot GJ, Lerner AJ, Debanne SM, Adunsky A, Dibello PM, Friedland RP (2004) Plasma homocysteine, vitamin B12 and folate in Alzheimers patients and healthy Arabs in Israel. J Neurol Sci 227, 109-113 (Pubitemid 39491133)
12. Mizrahi EH, Jacobsen DW, Debanne SM, Traore F, Lerner AJ, Friedland RP, Petot GJ (2003) Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging 7, 160-165 (Pubitemid 36560463)
13. Nilsson K, Gustafson L, Hultberg B (2002) Relation between plasma homocysteine and Alzheimers disease. Dement Geriatr Cogn Disord 14, 7-12 (Pubitemid 34621575)
14. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, DAgostino RB,Wilson PWF,Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimers disease. N Engl J Med 346, 476-483 (Pubitemid 34441738)
15. Miller JW, Green R, Mungas DM, Reed BR, Jagust WJ (2002) Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 58, 1471-1475 (Pubitemid 34552951)
16. Do KQ, Herrling PL, Streit P, Turski WA, Cuenod M (1986) In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum. J Neurosci 6, 2226-2234
17. Lipton SA, Kim WK, Choi YB, Kumar S, DEmilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl- D-aspartate receptor. Proc Natl Acad SciUS A 94, 5923-5928
18. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330, 613-622
19. Ho PI, Ashline D, Dhitavat S, Ortiz D, Collins SC, Shea TB, Rogers E (2003) Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol Dis 14, 32-42 (Pubitemid 37103177)
20. Morris RGM, DavisM(1994) The role ofNMDAreceptors in learning and memory. In The NMDA Receptor, Collingridge GL,Watkins JC, eds., 2nd ed., Oxford University Press, New York, 340-375
21. Weir DG, Molloy AM (2000) Microvascular disease and dementia in the elderly: Are they related to hyperhomocysteinemia? Am J Clin Nutr 71, 859-860 (Pubitemid 30176565)
22. Selkoe DJ (2001) Presenilin, Notch, and the genesis and treatment of Alzheimers disease. Proc Natl Acad Sci U S A 98, 11039-11041 (Pubitemid 32928679)
23. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimers disease. J Neurosci 22, 1752-1762 (Pubitemid 35386293)
24. Fuso A, Seminara L, Cavallaro RA, DAnselmi F, Scarpa S (2005) S-adenosylmethionine/homocysteine cycle alterations modifyDNAmethylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 28, 195-204 (Pubitemid 39656023)
25. Scarpa S, Fuso A, DAnselmi F, Cavallaro RA (2003) Presenilin gene silencing by S-adenosylmethionine: A treatment for Alzheimer disease? FEBS Lett 541, 145-148 (Pubitemid 36428933)
26. Liu R, Zhou X-W, Tanila H, Bjorkdahl C, Wang J-Z, Guan Z-Z, Cao Y, Gustafsson J-A,Winblad B, Pei J-J (2008) Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J Cell Mol Med 12, 241-257 (Pubitemid 351430466)
27. White AR, Huang X, Jobling MF, Barrow CJ, Beyreuther K, Masters CL, Bush AI, Cappai R (2001) Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimers-type neurodegenerative pathways. J Neurochem 76, 1509-1520 (Pubitemid 32198255)
28. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693-2698 (Pubitemid 23350966)
29. Hatzis CM, Bertsias GK, Linardakis M, Scott JM, KafatosAG (2006) Dietary and other lifestyle correlates of serum folate concentrations in a healthy adult population in Crete, Greece: A cross-sectional study. Nutr J 5, 5
30. Bailey L (2009) Folate in Health and Disease Second Edition, CRC Press, Taylor & Francis Group, Florida
31. Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di MinnoG(2001) Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5, 10-methylene tetrahydrofolate reductase gene in patients with Alzheimers dementia. A case-control study. Gerontology 47, 324-329 (Pubitemid 33135808)
32. Styczyńska M, Strosznajder JB, Religa D, Chodakowska- Zebrowska M, Pfeffer A, Gabryelewicz T, Czapski GA, Kobryś M, Karciauskas G, Barcikowska M (2008) Association between genetic and environmental factors and the risk of Alzheimers disease. Folia Neuropathol 46, 249-254
33. Basun H, Fratiglioni L, Winblad B (1994) Cobalamin levels are not reduced in Alzheimers disease: Results from a population-based study. J Am Geriatr Soc 42, 132-136 (Pubitemid 24057347)
34. Cascalheira JF, João SS, Pinhanços SS, Castro R, Palmeira M, Almeida S, Faria MC, Domingues FC (2009) Serum homocysteine: Interplay with other circulating and genetic factors in association to Alzheimers type dementia. Clin Biochem 42, 783-790
35. Abalan F, Zittoun J, Boutami C, Dugrais G, Manciet G, Decamps A, Antoniol B (1996) Plasma, red cell, and cerebrospinal fluid folate in Alzheimers disease. Encephale 22, 430-434
36. Van Dam F, Van Gool WA (2009) Hyperhomocysteinemia and Alzheimers disease: A systematic review. Arch Gerontol Geriatr 48, 425-430
37. Ellis K, Bush A, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager N, Lenzo N, Martins R, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, VillemagneV,Woodward M, Ames D, Group tAR (2009) The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimers disease. Int Psychogeriatr 21, 672-687
38. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 34, 939-944
39. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund L-O, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246 (Pubitemid 39222993)
40. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308 (Pubitemid 29120227)
41. Wechsler D (1945) A standardised memory scale for clinical use. J Psychology 19, 87-95
42. Delis D, Kramer J, Kaplan E, OberB(2000) California Verbal Learning Test-Second Edition
43. Meyers JE, Meyers KR (1995) Rey Complex Figure Test and Recognition Trial. Professional Manual
44. Strauss E, Sherman EMS, Spreen O (2006) A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd edn)
45. Delis DC, Kaplan E, Kramer JH. (2001) The Delis-Kaplan Executive Function System (D-KEFS), http://www.pearson assessments.com/HAIWEB/Cultures/enus/ Productdetail.htm? Pid=015-8091-108
46. WechslerD(1997)Wechsler Adult Intelligence Scale, 3rd edn (WAIS-III), http://www.pearsonpsychcorp.com.au/
47. Lewis J, Milligan G, HuntA(1995)NUTTAB95 Nutrient Data Table for Use in Australia
48. Giles G, Ireland P (1996) Dietary Questionnaire for Epidemiological Studies (Version 2
49. Giles GG, English DR (2002) The Melbourne Collaborative Cohort Study. IARC Sci Publ 156, 69-70
50. Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G (2000) The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24, 576-583 (Pubitemid 32094232)
51. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC (2007) Beta-amyloid imaging and memory in non-demented individuals: Evidence for preclinical Alzheimers disease. Brain 130, 2837-2844 (Pubitemid 350033975)
52. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, OKeefe G, Klunk WE, Mathis CA, Price JC, Masters CL,Villemagne VL (2007) Imaging beta-amyloid burden in aging and dementia. Neurology 68, 1718-1725 (Pubitemid 46763260)
53. R Development Core Team (2010). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/
54. Fox J (2003) Effect Displays in R for Generalised Linear Models. J Stat Software 8, 1-27 (Pubitemid 39217795)
55. Wickham H (2009) ggplot2: Elegant graphics for data analysis, Springer, New York
56. Venables WN, Ripley BD (2002) Modern Applied Statistics with S, Fourth Edition. Springer, New York
57. Fox J, Weisberg S (2011) An R Companion to Applied Regression, Second Edition, Thousand Oaks CA, Sage, http://socserv.socsci.mcmaster.ca/jfox/Books/ Companion
58. Box G, Cox D (1964) An analysis of transformations. J Royal Statist Soc B (Methol) 26, 211-252
59. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Royal Statist Soc B 57, 289-300
60. Hastie T, Pregibon D (1992) Generalized linear models. In Statistical Models in S, Chambers J, HastieT, eds.,Wadsworth & Brooks, Cole, Chapter 6
61. Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, OKeefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31, 1275-1283
62. Villemagne VL (2009) AIBL (Australian Imaging, Biomarkers and Lifestyle) flagship study of aging. Alzheimers Dement 5(Suppl), P1-P2
63. Selhub J (2006) The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136, 1726S- 1730S (Pubitemid 43765388)
64. Hoffer LJ (2004) Homocysteine remethylation and transsulfuration. Metab Clin Exp 53, 1480-1483
65. House JD, Jacobs RL, Stead LM, Brosnan ME, Brosnan JT (1999) Regulation of homocysteine metabolism. Adv Enzyme Regul 39, 69-91
66. Finkelstein JD (2007) Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 45, 1694-1699 (Pubitemid 350232969)
67. Amos R, Dawson D, Fish D, Lemming R, Linnell J (1994) Guidelines on the investigation and diagnosis of cobalamin and folate deficiencies. A publication of the British Committee for Standards in Haematology. BCSH General Haematology Test Force. Clin Lab Haematol 16, 101-115
68. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H (1998) Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 13, 235-239 (Pubitemid 28194997)
69. da Silva VC, Ramos FJdC, Freitas EM, de Brito-Marques PR, Cavalcanti MNdH, DAlmeidaV, Cabral-Filho JE, Muniz MTC (2006) Alzheimers disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms. Arq Neuropsiquiatr 64, 941-945 (Pubitemid 46120160)
70. Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, Mungas DM, Allen LH, Green R (2007) Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: Results from the Sacramento Area Latino Study on Aging. Am J Clin Nutr 85, 511-517 (Pubitemid 46220956)
71. Pitla S, Nagalla B (2009) Gender-related differences in the relationship between plasma homocysteine, anthropometric and conventional biochemical coronary heart disease risk factors in middle-aged Indians. Ann Nutr Metab 54, 1-6
72. McCaddon A, Tandy S, Hudson P, Gray R, Davies G, Hill D, Duguid J (2004) Absence of macrocytic anaemia in Alzheimers disease. Clin Lab Haematol 26, 259-263 (Pubitemid 39070691)
73. Engelborghs S, Vloeberghs E, Maertens K, Mariën P, Somers N, Symons A, Clement F, Ketels V, Saerens J, Goeman J, Pickut BA, Vandevivere J, De Deyn PP (2004) Correlations between cognitive, behavioural and psychological findings and levels of vitamin B12 and folate in patients with dementia. Int J Geriatr Psychiatry 19, 365-370 (Pubitemid 38461076)
74. Waly M, Deth R (2008) Neurodevelopmental Toxins Deplete Glutathione and Inhibit Folate and Vitamin B12-Dependent Methionine Synthase Activity: A Link between Oxidative Stress and Autism. FASEB J 22, 894.1
75. Collaboration HLT (1998) Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. Homocysteine Lowering Trialists Collaboration. BMJ 316, 894-898
76. Clarke R, Lewington S, Sherliker P, Armitage J (2007) Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia. Curr Opin Clin Nutr Metab Care 10, 32-39 (Pubitemid 44901131)
77. Malouf M, Grimley EJ, Areosa SA (2003) Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev, CD004514
78. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal LJ, Study ADC (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774-1783